PodcastIntel
Sign in Get Started Free
Prior Unknown
Prior Unknown

Paradromius Wins FDA Approval for High-Bandwidth BCI Trial

Nov 20, 2025 · 00:04:17
AI Summary
  • Paradromius gains FDA approval for high-bandwidth BCI trial.
  • Connexus implant aims to restore fluent speech for disabled.
  • This is a major milestone in the neurotech race.

More from Prior Unknown

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Prior Unknown and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →